<DOC>
	<DOCNO>NCT02058784</DOCNO>
	<brief_summary>Open label study Pracinostat test assess effect food single-dose pharmacokinetics healthy non-smoking smoking adult subject fast fed condition .</brief_summary>
	<brief_title>Study Evaluate Food Effect Single-dose Bioavailability Pracinostat Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy , adult , male female , 1855 year age , inclusive , screen . Cohort 1 : continuous nonsmoker use nicotinecontaining product least 6 month prior first dose confirmed urine cotinine test screening . Cohort 2 : moderate heavy smoker define &gt; 1 pack cigarette per day &gt; 39 cigarette per week least 6 month prior first dose confirmed urine cotinine test screening . Body Mass Index ( BMI ) ≥ 18.5 ≤ 32.0 kg/m2 screening . Medically healthy clinically significant medical history , physical examination , laboratory profile , vital sign ECGs , deem PI . For female nonchildbearing potential : A non vasectomize , male subject must agree use condom spermicide abstain sexual intercourse study 90 day beyond last dose study medication . ( No restriction require vasectomized male provide vasectomy perform 4 month prior study start . A male vasectomized less 4 month prior study start must follow restriction non vasectomized male ) . Understands study procedure inform consent form ( ICF ) , willing able comply protocol Subject mentally legally incapacitated significant emotional problem time screen visit expect conduct study . History presence clinically significant medical psychiatric condition disease opinion PI . History illness , opinion PI , might confound result study pose additional risk subject participation study . History presence alcoholism drug abuse within past 2 year prior screen . History presence hypersensitivity idiosyncratic reaction study medication relate compound . History prolong QT syndrome . Positive urine drug alcohol result screen checkin . Positive result screen HIV , HBsAg HCV . Seated blood pressure le 90/40 mmHg great 140/90 mmHg screening . Seated heart rate lower 40 bpm high 99 bpm screening . QTcF interval , &gt; 430 msec ( male ) &gt; 450 msec ( female ) deem clinically abnormal PI screening Period 1 checkin Unable refrain anticipates use : Any drug , include prescription nonprescription medication , herbal remedy , vitamin supplement begin approximately 14 day prior first dose study medication throughout study . Any drug know significant inducer CYP enzyme , include St. John 's Wort , 28 day prior first dose dose study medication throughout study . Appropriate source consult PI designee confirm lack PK/pharmacodynamics interaction study medication . Have diet incompatible onstudy diet , opinion PI , within 28 day prior first dose study medication ( ) , throughout study . Hemoglobin , platelet count absolute neutrophil low limit normal screening . Potassium magnesium lower limit normal screening . Aspartate aminotransferase alanine aminotransferase upper limit normal screening . Donation blood significant blood loss within 56 day prior first dose study medication . Plasma donation within 7 day prior first dose study medication . Participation another clinical trial within 28 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>